Expertise in
6
conditions

Dr. Gary Gottlieb

Gastroenterology
TMcOne-Wilmot, Adult Multispecialty
1396 N Wilmot Rd, 
Tucson, AZ 
Offers Telehealth
Expertise in
6
conditions
TMcOne-Wilmot, Adult Multispecialty
1396 N Wilmot Rd, 
Tucson, AZ 

Overview

Gary Gottlieb is a Gastroenterologist in Tucson, Arizona. Dr. Gottlieb is highly rated in 6 conditions, according to our data. His top areas of expertise are Heartburn, Esophagitis, Gastroesophageal Reflux Disease (GERD), and Hemorrhoids.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Gastroenterology

Licenses

Internal Medicine in AZ

Hospital Affiliations

Tucson Medical Center

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 12 Less Insurance Carriers -

Locations

TMcOne-Wilmot, Adult Multispecialty
1396 N Wilmot Rd, Tucson, AZ 85712

Additional Areas of Focus

Dr. Gottlieb has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Open-label Continuation Study With Budesonide Oral Suspension (BOS) for Adolescent and Adult Subjects With Eosinophilic Esophagitis (EoE)
Enrollment Status: Terminated
Publish Date: February 19, 2025
Intervention Type: Drug
Study Drug: Budesonide oral suspension
Study Phase: Phase 3
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
A Phase 3, Multicenter, Double-blind Extension Study to Evaluate Maintenance of Efficacy of Oral Budesonide Suspension (OBS) and Long-term Treatment Effect of OBS in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis (EoE)
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Oral Budesonide Suspension (OBS) in Adolescent and Adult Subjects (11 to 55 Years of Age, Inclusive) With Eosinophilic Esophagitis: A Phase 3 Randomized, Double-blind, Placebo-controlled Study
Enrollment Status: Completed
Publish Date: February 19, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
A Phase 3 Long-term Safety Extension Study of SHP647 in Subjects With Moderate to Severe Ulcerative Colitis or Crohn's Disease (AIDA)
Enrollment Status: Completed
Publish Date: June 21, 2024
Intervention Type: Drug
Study Drug: Ontamalimab
Study Phase: Phase 3
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
A Phase 2, Multicenter, Randomized, Parallel-Arm, Placebo-Controlled Study of LY3074828 in Subjects With Active Crohn's Disease (SERENITY)
Enrollment Status: Completed
Publish Date: August 30, 2022
Intervention Type: Drug
Study Drug: Mirikizumab
Study Phase: Phase 2
Specimen Collection Study for Cancer
Specimen Collection Study for Cancer
Enrollment Status: Completed
Publish Date: March 02, 2022
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Maintenance Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 303)
Enrollment Status: Completed
Publish Date: January 14, 2022
Intervention Type: Other, Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 301)
Enrollment Status: Terminated
Publish Date: June 14, 2021
Intervention Type: Other, Drug
Study Phase: Phase 3
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 8 Less Clinical Trials

1 Total Publications

The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System: a multicenter clinical study in 257 subjects.
The validity of breath collection bags method in detecting Helicobacter pylori using the novel BreathID ® Hp Lab System: a multicenter clinical study in 257 subjects.
Journal: Therapeutic advances in gastrointestinal endoscopy
Published: October 20, 2018
Similar Doctors
Expertise in
45
conditions
Dr. Miguel Arenas
Gastroenterology
Expertise in
45
conditions
Dr. Miguel Arenas
Gastroenterology

Miguel A Arenas MD PC

7445 E Tanque Verde Rd, 
Tucson, AZ 
 (2.5 miles away)
520-722-0744
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Miguel Arenas is a Gastroenterologist in Tucson, Arizona. Dr. Arenas is highly rated in 45 conditions, according to our data. His top areas of expertise are Chronic Erosive Gastritis, Gastroesophageal Reflux Disease (GERD), Congenital Diaphragmatic Hernia, Gastrectomy, and Colonoscopy. Dr. Arenas is currently accepting new patients.

Joshua Melson
Expertise in
8
conditions
Dr. Joshua Melson
Gastroenterology
Expertise in
8
conditions
Dr. Joshua Melson
Gastroenterology

Banner - University Medicine North

3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
 (4.2 miles away)
520-694-8888
Languages Spoken:
English, Hebrew
See accepted insurances
Accepting New Patients
Offers Telehealth

I enjoy time with my family. I also enjoy exploring the outdoors especially since I have moved to Southern Arizona. Dr. Melson is highly rated in 8 conditions, according to our data. His top areas of expertise are Colorectal Polyps, Colorectal Cancer, Watermelon Stomach, Colonoscopy, and Endoscopy.

Sasha Taleban
Expertise in
9
conditions
Dr. Sasha Taleban
Gastroenterology
Expertise in
9
conditions
Dr. Sasha Taleban
Gastroenterology

Banner - University Medicine North

3838 North Campbell Avenue, Building 2, 
Tucson, AZ 
 (4.2 miles away)
520-694-8888
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Sasha Taleban is a Gastroenterologist in Tucson, Arizona. Dr. Taleban is highly rated in 9 conditions, according to our data. His top areas of expertise are Crohn's Disease, Ulcerative Colitis, Viral Gastroenteritis, Endoscopy, and Colonoscopy. Dr. Taleban is currently accepting new patients.

Frequently Asked Questions about Dr. Gary Gottlieb

How do I make an appointment with Dr. Gary Gottlieb?

You can book an appointment with Dr. Gary Gottlieb by calling their office at 520-420-2250. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Gary Gottlieb a top-rated expert for Heartburn?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Gary Gottlieb is classified as an Advanced expert for Heartburn, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Gary Gottlieb specialize in?

While Dr. Gary Gottlieb is a Gastroenterology, they have specific expertise in Heartburn, Esophagitis, and Gastroesophageal Reflux Disease (GERD). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Dr. Gary Gottlieb participate in research or clinical trials?

Yes. Dr. Gary Gottlieb has published 1 articles and abstracts on conditions like Heartburn. You can view a list of Dr. Gary Gottlieb's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Gary Gottlieb accept my insurance?

Dr. Gary Gottlieb accepts most major insurance plans, including Aetna and Alignment Health Plan. We recommend calling the office directly at 520-420-2250 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Gottlieb's expertise for a condition
ConditionClose
      View All 36 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile